- $1.68bn
- $1.73bn
- $792.32m
- 98
- 46
- 35
- 62
Annual balance sheet for Goodrx Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 969 | 941 | 757 | 672 | 448 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 97.3 | 126 | 122 | 160 | 161 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,086 | 1,089 | 920 | 873 | 659 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 50.8 | 49.3 | 55.7 | 45.9 | 40.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,470 | 1,608 | 1,605 | 1,589 | 1,388 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 59.6 | 81.1 | 76.3 | 123 | 124 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 759 | 776 | 790 | 827 | 663 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 711 | 832 | 815 | 762 | 725 |
Total Liabilities & Shareholders' Equity | 1,470 | 1,608 | 1,605 | 1,589 | 1,388 |
Total Common Shares Outstanding |